JAK3 and nasopharyngeal carcinoma: By screening chemical compounds, we identified a JAK3 inhibitor, TCS21311, as a substitute for BMP7 in the expansion culture developed by Li et al. [18] and revealed a novel inhibitory role of BMP7 in JAK3-STAT3 signaling for NPC expansion [19].